Abstract:Background Zinc transport proteins (ZIP and ZnT), metallothioneins (MT) and protein kinase CK2 are involved in dysregulation of zinc homeostasis in breast and prostate cancer cells. Following up our previous research, we targeted ZIP12, ZnT1, MT2A and CK2 in this study by investigating their expression levels and protein localisation. Methods Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunofluorescence confocal microscopy were employed to quantify the expression of ZIP12, ZnT1, MT2A and CK2 subunits in a panel of breast and prostate cell lines without or with extracellular zinc exposure. The cellular localisations of these target proteins were also examined by immunofluorescence confocal microscopy. Results In response to the extracellular zinc exposure, the gene expression was elevated for SLC39A12 (ZIP12), SLC30A1 (ZnT1) and MT2A (MT2A) in normal prostate epithelial cells (RWPE-1) in contrast to their cancerous counterparts (PC3 and DU145), whilst the gene expression was higher for SLC39A12 (ZIP12) and SLC30A1 (ZnT1) in both normal (MCF10A) and basal breast cancer cells (MDA-MB-231) compared to luminal breast cancer cells (MCF-7). At the protein level, the expression for both ZIP12 and ZnT1 was trending lower in the time course for the breast cancer cells whilst their expression was remained constant in the normal breast epithelial cells. The expression of ZIP12 in prostate cancer cells was higher than the normal prostate cells. The protein expression for CK2 α/αꞌ and CK2β was markedly higher in prostate cancer cells than the normal prostate cells. Upon extracellular zinc exposure, ZIP12 was, for the first time, conspicuously localised in the plasma membrane of breast cancer cells but not in normal breast epithelial cells and prostate cells. ZnT1 is only localised in the plasma membrane of breast cancer cells. MT2A is distinctively seen close to the plasma membrane in breast cancer cells. CK2 is also for the first time shown to be localised in proximity to the plasma membrane of breast cancer cells. Conclusion The findings, particularly the localisation of ZIP12 and CK2, are novel and significant for our understanding of zinc homeostasis in breast and prostate cancer cells.

Zinc’s Association with the CmPn/CmP Signaling Network in Breast Cancer Tumorigenesis

Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc

Zinc transporters and dysregulated channels in cancers.

Zinc Signaling in the Mammary Gland: For Better and for Worse

Zinc Favors Triple-Negative Breast Cancer’s Microenvironment Modulation and Cell Plasticity

Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma

Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells

Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review

A Systematic Study on Zinc-Related Metabolism in Breast Cancer

Distinctive expression and cellular localisation of zinc homeostasis-related proteins in breast and prostate cancer cells

Transcriptomic insights into the zinc homeostasis of MCF-7 breast cancer cells via next-generation RNA sequencing.

Expression profiles of the genes associated with zinc homeostasis in normal and cancerous breast and prostate cells

Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets

Review Article on Molecular Basis of Zinc and Copper Interactions in Cancer Physiology

Paradoxical zinc toxicity and oxidative stress in the mammary gland during marginal dietary zinc deficiency

Zinc Transporters and the Progression of Breast Cancers

Serum copper and zinc levels in breast cancer: A meta-analysis

A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer

Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein

The Role of the Metabolism of Zinc and Manganese Ions in Human Cancerogenesis

Analysis of plasma and erythrocyte zinc levels in premenopausal women with breast cancer